title: Development of interfering RNA agents to inhibit SARS-associated coronavirus infection and replication.
authors.affiliation: Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong SAR, China. mlhe@cuhk.edu.hk
authors.forename: M L
authors.initials: ML
authors.lastname: He
authors.forename: B J
authors.initials: BJ
authors.lastname: Zheng
authors.forename: Y
authors.initials: Y
authors.lastname: Chen
authors.forename: K L
authors.initials: KL
authors.lastname: Wong
authors.forename: J D
authors.initials: JD
authors.lastname: Huang
authors.forename: M C
authors.initials: MC
authors.lastname: Lin
authors.forename: K Y
authors.initials: KY
authors.lastname: Yuen
authors.forename: J J Y
authors.initials: JJ
authors.lastname: Sung
authors.forename: H F
authors.initials: HF
authors.lastname: Kung
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D002478:Cells, Cultured; D007668:Kidney / Q000166:cytology; D008253:Macaca mulatta; D012313:RNA / Q000096:biosynthesis* / Q000235:genetics; D034741:RNA, Small Interfering / Q000096:biosynthesis* / Q000235:genetics / Q000494:pharmacology*; D045473:Severe acute respiratory syndrome-related coronavirus / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents; D034741:RNA, Small Interfering; C039919:RNA, recombinant; D012313:RNA